|
2002 |
GenoLogics founded |
|
|---|---|---|
|
2003 |
Initiates development of LIMS specifically for biological research |
|
|
2004 |
Releases first product for proteomics market |
|
|
2005 |
Expands sales team into Europe |
|
|
2005 |
Secures Series A venture capital financing |
|
|
2006 |
Secures Series B venture capital financing |
|
|
2007 |
Launches LIMS product for genomics market |
|
|
2007 |
Works with Affymetrix to achieve GeneChip-Compatible® status |
|
|
2008 |
Signs largest deal in company’s history with a top tier pharma company |
|
|
2008 |
Illumina selects GenoLogics as its ‘Preferred NGS LIMS Partner’ |
|
|
2008 |
Secures Series C venture capital financing |
|
|
2009 |
Enters next-generation sequencing (NGS) market |
|
|
2009 |
Partners with Applied Biosystems to support SOLiD™ sequencing platform |
|
|
2009 |
Installs first LIMS for NGS in major sequencing center |
|
|
2011 |
GenoLogics and Illumina sign co-selling agreement for NGS LIMS |
|
|
2011 |
General release of APIs for genomics customers |
|
|
2011 |
Launches first preconfigured product for Illumina NGS |
|
|
2011 |
GenoLogics raises $8M in strategic financing round |
|
|
2012 |
GenoLogics launches Clarity LIMS |
|
